Voices
Mélanie Janson on Hematological Toxicities After Immune Checkpoint Inhibitors are Used – MASCC
Mélanie Janson / LinkedIn

Mélanie Janson on Hematological Toxicities After Immune Checkpoint Inhibitors are Used – MASCC

The Multinational Association of Supportive Care in Cancer (MASCC) shared on LinkedIn:

“In this video, Dr. Mélanie Janson presents a summary of her abstract on hematological toxicities after immune checkpoint inhibitors are used, including practical recommendations for treatment.

Watch the video”

To which Mélanie Janson, Junior Doctor in Medical Oncology at Centre François Baclesse, added:

“Thanks for this opportunity to make a summary of our practical recommendations at the MASCC 2026 congress in Melbourne!”

Other articles about Immunotherapy on OncoDaily.

 

Australia cancer immune checkpoint inhibitor MASCC MASCC 2026 Mélanie Janson Melbourne OncoDaily Oncology The Multinational Association of Supportive Care in Cancer